Archive, Historians, CREW Sue White House, Seek to Preserve Presidential Records During the Transition

Archive, Historians, CREW Sue White House, Seek to Preserve Presidential Records During the Transition

The National Security Archive, the Society for Historians of American Foreign Relations, the American Historical Association, and the Citizens for Responsibility and Ethics in Washington today filed suit against President Donald Trump in his official capacity, seeking to enforce the Presidential Records Act and prevent any destruction of records during the presidential transition.

The lawsuit cites the inadequacy of current White House policies that only require a screenshot of instant messages to be saved, preserving only the graphic content, when the law (as amended in 2014) requires “a complete copy” to be preserved, including digital links and attachments.

Covid-19 Likely in U.S. in Mid-December 2019, CDC Scientists Report

Covid-19 Likely in U.S. in Mid-December 2019, CDC Scientists Report

In analyzing the blood samples, the CDC scientists found antibodies in 39 samples from California, Oregon and Washington state collected between Dec. 13 and Dec. 16.

The findings suggest there were isolated cases of coronavirus infection on the U.S. West Coast in mid-December, the scientists wrote.

They also found 67 samples with antibodies in Massachusetts, Michigan, Wisconsin or Iowa, and Connecticut or Rhode Island collected between Dec. 30 and Jan. 17.

Research:

Serologic testing of U.S. blood donations to identify SARS-CoV-2-reactive antibodies: December 2019-January 2020

Prosecutors Say They’re Spies, But Charges Tell a Different Story

Prosecutors Say They’re Spies, But Charges Tell a Different Story

A review of court filings and transcripts of hearings shows the charges and allegations are far less serious, frequently involving misstatements surrounding a visa application—a violation often punished with less than a year in prison. In only one case has a researcher been charged with acting as a foreign government agent, and she was allowed to return to China eight months before her indictment, leaving little chance she’ll face legal proceedings in the U.S.

Barr — No evidence of fraud that’d change election outcome

Barr — No evidence of fraud that’d change election outcome

In an interview with The Associated Press, Barr said U.S. attorneys and FBI agents have been working to follow up specific complaints and information they’ve received, but they’ve uncovered no evidence that would change the outcome of the election.

Barr didn’t name Powell specifically but said: “There’s been one assertion that would be systemic fraud and that would be the claim that machines were programmed essentially to skew the election results. And the DHS and DOJ have looked into that, and so far, we haven’t seen anything to substantiate that,” Barr said.

The Fixer has spoken! Now stop crying and accept the results!

The Past Lives On: The Elite Strategy To Divide and Conquer

The Past Lives On: The Elite Strategy To Divide and Conquer

The truth is that both the Trump voters and the Biden voters have been taken for a ride. It is a game, a show, a movie, a spectacle. It hasn’t changed much since 1969; the rich have gotten richer and the poor, working, and middle classes have gotten poorer and more desperate. Those who have profited have embraced the fraud.

H/T: The Most Revolutionary Act

Emergency approval of coronavirus vaccines is not guaranteed, FDA commissioner says

Emergency approval of coronavirus vaccines is not guaranteed, FDA commissioner says

Career scientists at the FDA are reviewing raw data from the Pfizer and Moderna trials for the first time, investigating any adverse events or side effects that transpired over the course of the trials, different levels of effectiveness among populations and age groups, and whether individuals who were already infected by the coronavirus might have had any unexpected reactions to the vaccine doses.

Hahn said they will also be looking for evidence that the vaccines lead to increased respiratory infections – a concern with vaccines produced for other coronaviruses, such as SARS and MERS – and whether the use of a relatively new method of vaccine development, known as messenger RNA technology, poses any significant risks.